Intestinal Cell News 6.17 May 15, 2020 | |
| |
TOP STORYHigh-Resolution mRNA and Secretome Atlas of Human Enteroendocrine Cells Researchers describe an organoid-based platform for functional studies of human enteroendocrine cells (EECs). EEC formation was induced in vitro by transient expression of NEUROG3. A set of gut organoids was engineered in which the major hormones were fluorescently tagged. [Cell] Abstract | Graphical Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Infection of Bat and Human Intestinal Organoids by SARS-CoV-2 Investigators showed the establishment and characterization of expandable intestinal organoids derived from horseshoe bats of the Rhinolophus sinicus species that could recapitulate bat intestinal epithelium. [Nat Med] Full Article Zonation of Ribosomal DNA Transcription Defines a Stem Cell Hierarchy in Colorectal Cancer Researchers discovered that the majority of ribosomal DNA transcription and protein synthesis in colorectal cancers occurs in a limited subset of tumor cells that localized in defined niches [Cell Stem Cell] Abstract | Graphical Abstract | Press Release The authors showed that mouse intestinal tumors carrying Trp53 gain-of-function mutation with loss of heterozygosity were enriched in metastatic lesions when heterozygous Trp53 mutant cells were transplanted. [Nat Commun] Full Article Both in vitro and in vivo studies showed that of M13@Ag treatment could scavenge Fusobacterium nucleatum in gut and led to reduction in myeloid-derived suppressor cell amplification in the tumor site. [Sci Adv] Full Article Scientists showed that LAMB3 was overexpressed in colorectal cancer and that this overexpression was correlated with tumor metastasis and poor prognosis. [Oncogene] Abstract The authors investigated the expression of circRNAs in five gastric cancer (GC) tissues with metastasis and five GC tissues without metastasis by microarray analysis. [Mol Ther Nucleic Acids] Abstract | Full Article | Graphical Abstract USP38 Regulates the Stemness and Chemoresistance of Human Colorectal Cancer via Regulation of HDAC3 Scientists identified that an ubiquitin-specific protease, USP38, was downregulated in clinical colorectal cancer samples and colorectal cancer cell lines. [Oncogenesis] Full Article Allosteric Inhibitor of β-Catenin Selectively Targets Oncogenic Wnt Signaling in Colon Cancer The authors have identified C2, a novel β-catenin inhibitor, which was a small molecule that bound to a novel allosteric site on the surface of β-catenin. C2 selectively inhibited β-catenin, lowered its cellular load and significantly reduced viability of β-catenin-driven cancer cells. [Sci Rep] Full Article Investigators showed that oral administration of single dose of sitagliptin on D7 remarkably inhibited DPP enzyme activity in both serum and intestine of dextran sulfate sodium-induced colitic mice. [Acta Pharmacol Sin] Abstract Intestinal organoid units were isolated from C57BL/6 mice and cultured in Matrigel in the presence or absence of recombinant human rhRSPO1. Throughout the culture, organoid unit growth and survival rates were evaluated, and cells were harvested on day three. [Front Bioeng Biotechnol] Abstract TMPRSS2 and TMPRSS4 Promote SARS-CoV-2 Infection of Human Small Intestinal Enterocytes Scientists report productive infection of SARS-CoV-2 in ACE2+ mature enterocytes in human small intestinal enteroids. Expression of two mucosa-specific serine proteases, TMPRSS2 and TMPRSS4, facilitated SARS-CoV-2 spike fusogenic activity and promoted virus entry into host cells. [Sci Immunol] Full Article Subscribe to one of our other 19 science newsletters such as Pulmonary Cell News & ESC & iPSC News. | |
| |
REVIEWSThe authors evaluate the recent advances in Cryptosporidium culturing techniques and propose future directions for research that may build upon these successes. [Microorganisms] Full Article Visit our reviews page to see a complete list of reviews in the intestinal cell research field. | |
| |
INDUSTRY NEWSCardiff Oncology, Inc. announced an agreement with PoC Capital, LLC, to fund the completion of its ongoing Phase Ib/II clinical trial in patients with KRAS-mCRC. [Cardiff Oncology, Inc.] Press Release AstraZeneca and Daiichi Sankyo Company, Limited’s Enhertu has been granted Breakthrough Therapy Designation in the US for the treatment of patients with HER2-positive unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma who have received two or more prior regimens including trastuzumab. [AstraZeneca] Press Release | |
| |
POLICY NEWSAmid the COVID-19 Pandemic, Some Scientists Bring the Bench Home While some scientists have turned to writing manuscripts and grants and making inventories of their freezers to keep busy while away from the bench, others have brought experiments home, turning bathrooms, laundry rooms, and kitchens into makeshift labs-sometimes seeing an opportunity to explore new questions, other times trying out of desperation to prevent projects from moving backwards. [The Scientist] Editorial Scientists Are Drowning in COVID-19 Papers. Can New Tools Keep Them Afloat? Backed by large technology firms and the White House, a loose-knit army of data scientists, software developers, and journal publishers are racing to create digital collections holding thousands of freely available papers that could be useful to ending the pandemic, and scrambling to build data-mining and search tools that can help researchers quickly find the information they seek. [ScienceInsider] Editorial House Democrats Include Research Dollars in Latest Pandemic Relief Package For US scientists, the good news is that the $3 trillion spending bill unveiled contains billions of dollars in new research funding. The bad news is that the bill is only a marker for negotiations with Senate Republicans and the White House on what more the federal government should do to help the country deal with the devastating economic and health effects of the pandemic. [ScienceInsider] Editorial
| |
EVENTSIn light of COVID-19, many conferences are being cancelled or postponed. As such: We are suspending new event postings in our newsletters and on Twitter. Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Position – Gastrointestinal Disorders (KU Leuven) Postdoctoral Position – Colorectal Carcinogenesis (Universitätsklinikum Erlangen) Postdoctoral Fellow – Cancer Biology (Augusta University) Group Leader – Cancer Biology (Northwestern University) Research Technician – Cancer (Oklahoma Medical Research Foundation) PhD Student – Cancer (Danish Cancer Society Research Center) Faculty Positions – Precision Medicine (Sun Yat-Sen University) Postdoctoral Position – Cancer Research (The Ohio State University) Lab Manager – Intestinal Research (Howard Hughes Medical Institute) Research Scientist – In Vivo Research on Wnt Signaling in Self-Renewal (Surrozen) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Intestinal Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|